Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

• المؤلفون الرئيسيون: Latonen, L, Afyounian, E, Jylhä, A, Nättinen, J, Aapola, U, Annala, M, Kivinummi, K.K, Tammela, T.T.L, Beuerman, R.W, Uusitalo, H, Nykter, M, Visakorpi, T
• مؤلفون آخرون: DUKE-NUS MEDICAL SCHOOL
• التنسيق: مقال
• منشور في: Nature Publishing Group 2020
• الموضوعات: messenger RNA; microRNA; proteome; transcriptome; tumor protein; cancer; castration; citric acid; gene expression; genetic analysis; methylation; protein; proteomics; adult; aged; Article; cancer growth; castration resistant prostate cancer; citric acid cycle; controlled study; DNA methylation; gene dosage; gene expression level; genomics; human; human tissue; male; mass spectrometry; prostate cancer; prostate hypertrophy; proteogenomics; transcriptomics; disease exacerbation; gene expression regulation; genetics; genome-wide association study; metabolism; middle aged; pathology; prostate; Aged; Citric Acid Cycle; Disease Progression; DNA Methylation; Gene Dosage; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Genomics; Humans; Male; MicroRNAs; Middle Aged; Neoplasm Proteins; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms, Castration-Resistant; RNA, Messenger; Transcriptome
• الوصول للمادة أونلاين: https://scholarbank.nus.edu.sg/handle/10635/178420

10.1038/s41467-018-03573-6